Conolidine analogues as selective ACKR3 modulators for the treatment of cancer and cardiovascular diseases

Keyphrases

• Cardiovascular Disease 100%
• Cancer Treatment 100%
• Cancer Disease 100%
• Atypical Chemokine Receptor 3 100%
• Conolidine 100%
• Autoimmune Disease 66%
• Alzheimer's Disease 33%
• Obesity 33%
• Polypeptide 33%
• Wound Healing 33%
• Human Immunodeficiency Virus Infection 33%
• Inflammatory Diseases 33%
• Multiple Sclerosis Treatment 33%
• Patient Prognosis 33%
• Stem Cell Differentiation 33%
• In Vitro Techniques 33%
• Vascularization 33%
• Neuronal Dysfunction 33%
• Kidney Disease 33%
• Preeclampsia 33%
• Fibrosis Diseases 33%
• Atherosclerotic Vascular Disease 33%
• Brain Dysfunction 33%
• Stem Cell Mobilization 33%
• Alzheime's Disease 33%
• Renal Dysfunction 33%
• Demyelinating Disease 33%

Medicine and Dentistry

• Cancer Treatment 100%
• Cardiovascular Disease 100%
• Chemokine Receptor 100%
• In Vitro 66%
• Malignant Neoplasm 33%
• Ex Vivo 33%
• Alzheimer's Disease 33%
• Brain Disease 33%
• Multiple Sclerosis 33%
• Human Immunodeficiency Virus Infection 33%
• Vascularity 33%
• Wound Healing 33%
• Fibrosis 33%
• Clinically Isolated Syndrome 33%
• Cell Differentiation 33%
• Polypeptide 33%
• Pre-Eclampsia 33%
• Autoimmune Disease 33%
• Vascular Disease 33%
• Diseases 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Malignant Neoplasm 100%
• Chemokine Receptor 100%
• Cardiovascular Disease 100%
• Inflammatory Disease 33%
• Human Immunodeficiency Virus Infection 33%
• Alzheimer's Disease 33%
• Autoimmune Disease 33%
• Multiple Sclerosis 33%
• Fibrosis 33%
• Brain Disease 33%
• Wound Healing 33%
• Polypeptide 33%
• Vascular Disease 33%
• Kidney Dysfunction 33%
• Preeclampsia 33%
• Demyelinating Disease 33%
• Diseases 33%